Virtual Event: CRISPR Quest
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET
Last summer Intellia reported the first data showing that CRISPR could be used in the body to combat a disease — in this case, a rare nerve disorder. That early data was so eye-catching it was published in the New England Journal of Medicine. But what are the next steps? The company’s CEO joins STAT to lay them out and answer your questions.
